Dora Janeth Fonseca

812 total citations
65 papers, 457 citations indexed

About

Dora Janeth Fonseca is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dora Janeth Fonseca has authored 65 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Genetics and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dora Janeth Fonseca's work include Muscle Physiology and Disorders (8 papers), Genomics and Rare Diseases (6 papers) and Neurogenetic and Muscular Disorders Research (6 papers). Dora Janeth Fonseca is often cited by papers focused on Muscle Physiology and Disorders (8 papers), Genomics and Rare Diseases (6 papers) and Neurogenetic and Muscular Disorders Research (6 papers). Dora Janeth Fonseca collaborates with scholars based in Colombia, France and United States. Dora Janeth Fonseca's co-authors include Heidi Mateus, Carlos Martín Restrepo, Paul Laissue, Oscar Ortega‐Recalde, Alberto Vélez-van-Meerbeke, Claudia Talero‐Gutiérrez, Liliana Catherine Patiño, Diego A. Forero, Carlos‐Alberto Calderón‐Ospina and Claudia Silva and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Dora Janeth Fonseca

56 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dora Janeth Fonseca Colombia 13 133 101 79 62 58 65 457
Paolo Gravina Italy 13 250 1.9× 48 0.5× 46 0.6× 37 0.6× 69 1.2× 17 576
Carlos Martín Restrepo Colombia 13 142 1.1× 99 1.0× 47 0.6× 11 0.2× 15 0.3× 48 398
Qin Xie China 16 223 1.7× 34 0.3× 116 1.5× 25 0.4× 106 1.8× 42 763
Susana P. Campos United States 12 240 1.8× 90 0.9× 25 0.3× 11 0.2× 116 2.0× 17 690
C.E. Flück Switzerland 12 223 1.7× 258 2.6× 100 1.3× 12 0.2× 29 0.5× 16 566
Dor Mohammad Kordi-Tamandani Iran 17 481 3.6× 147 1.5× 41 0.5× 36 0.6× 134 2.3× 63 895
Ting Xie China 12 97 0.7× 28 0.3× 43 0.5× 12 0.2× 99 1.7× 47 412
Mireia Vilardell Spain 12 243 1.8× 170 1.7× 70 0.9× 16 0.3× 15 0.3× 27 553
Joshua Backman United States 7 177 1.3× 315 3.1× 26 0.3× 20 0.3× 32 0.6× 9 605

Countries citing papers authored by Dora Janeth Fonseca

Since Specialization
Citations

This map shows the geographic impact of Dora Janeth Fonseca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Janeth Fonseca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Janeth Fonseca more than expected).

Fields of papers citing papers by Dora Janeth Fonseca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora Janeth Fonseca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Janeth Fonseca. The network helps show where Dora Janeth Fonseca may publish in the future.

Co-authorship network of co-authors of Dora Janeth Fonseca

This figure shows the co-authorship network connecting the top 25 collaborators of Dora Janeth Fonseca. A scholar is included among the top collaborators of Dora Janeth Fonseca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Janeth Fonseca. Dora Janeth Fonseca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baracaldo-Santamaría, Daniela, et al.. (2021). Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation. International Journal of Molecular Sciences. 22(15). 8090–8090. 23 indexed citations
2.
Oviedo, Juan Mauricio Pardo, et al.. (2021). A Pharmacogenetic Study of CYP2C19 in Acute Coronary Syndrome Patients of Colombian Origin Reveals New Polymorphisms Potentially Related to Clopidogrel Therapy. Journal of Personalized Medicine. 11(5). 400–400. 6 indexed citations
3.
Calderón‐Ospina, Carlos‐Alberto, et al.. (2020). Possible Genetic Determinants of Response to Phenytoin in a Group of Colombian Patients With Epilepsy. Frontiers in Pharmacology. 11. 555–555. 12 indexed citations
4.
Fonseca, Dora Janeth, et al.. (2019). Mutant GNLY is linked to Stevens–Johnson syndrome and toxic epidermal necrolysis. Human Genetics. 138(11-12). 1267–1274. 6 indexed citations
5.
Restrepo, Carlos Martín, et al.. (2018). Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients. Pharmacogenomics and Personalized Medicine. Volume 11. 169–178. 12 indexed citations
6.
Fonseca, Dora Janeth, et al.. (2014). Evidencia de asociación entre el genotipo 10/10 de DAT1 y endofenotipos del trastorno por déficit de atención/hiperactividad. Neurología. 30(3). 137–143. 11 indexed citations
7.
Forero, Diego A., et al.. (2013). Evidence of association between SNAP25 gene and attention deficit hyperactivity disorder in a Latin American sample. ADHD Attention Deficit and Hyperactivity Disorders. 6(1). 19–23. 30 indexed citations
8.
Mateus, Heidi, et al.. (2011). [Analysis of microdeletions in 22q11 in Colombian patients with congenital heart disease].. PubMed. 52(4). 334–43. 2 indexed citations
9.
Silva, Claudia, et al.. (2010). ANÁLISIS CLÍNICO Y MOLECULAR DE UNA PACIENTECON PENTASOMIA DEL CROMOSOMA X.. SHILAP Revista de lepidopterología.
10.
Fonseca, Dora Janeth, et al.. (2010). Fibrosis quística afectaría a uno de cada cinco mil recién nacidos. instname:Universidad del Rosario. 1 indexed citations
11.
Fonseca, Dora Janeth, Claudia Silva, Heidi Mateus, & Carlos Martín Restrepo. (2008). Deletions identification in female carriers of Duchennes muscular distrophy. 33(2). 63–67. 1 indexed citations
12.
Sánchez, Magda Carolina, et al.. (2008). Glucose-6-phosphate dehydrogenase deficiency: enzimatic and molecular analysis in a Bogotá population.. Colombia medica. 39(2.Supl.2). 14–23. 3 indexed citations
13.
Sánchez, Magda Carolina, et al.. (2008). Deficiencia de glucosa 6 fosfato deshidrogenasa: análisis enzimático y molecular en una población de Bogotá. Colombia medica. 39(2). 14–23. 3 indexed citations
14.
Fonseca, Dora Janeth, Claudia Silva, & Heidi Mateus. (2008). Detección de portadoras de distrofia muscular de Duchenne en familias colombianas mediante análisis de microsatélites. Colombia medica. 39(2). 7–13. 2 indexed citations
15.
Silva, Claudia, et al.. (2008). Utilidad de la citogenética en la medicina actual Visión histórica y aplicación. Redalyc (Universidad Autónoma del Estado de México). 33(4). 309–316.
16.
Silva, Claudia, et al.. (2007). Hemofilia: diagnóstico molecular y alternativas de tratamiento. Colombia medica. 38(3). 308–315. 3 indexed citations
17.
Mateus, Heidi, et al.. (2006). PCR-heteroduplex by grouping: Rapid screening carrier method for cystic fibrosis F508del mutation in Colombia.. Colombia medica. 37(3). 176–182. 1 indexed citations
18.
Mateus, Heidi, et al.. (2006). PCR-heterodúplex por agrupamiento: Implementación de un método de identificación de portadores de la mutación más común causal de fibrosis quística en Colombia. Colombia medica. 37(3). 176–182. 3 indexed citations
19.
Potolicchio, Ilaria, Sriram Chitta, Xiaonan Xu, et al.. (2005). Conformational Variation of Surface Class II MHC Proteins during Myeloid Dendritic Cell Differentiation Accompanies Structural Changes in Lysosomal MIIC. The Journal of Immunology. 175(8). 4935–4947. 32 indexed citations
20.
Silva, Claudia, et al.. (2005). Duchenne and Becker's muscle dystrophy: A molecular vision. 30(3). 112–116. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Gravina Breakdown of academic impact, for papers by Carlos Martín Restrepo Breakdown of academic impact, for papers by Qin Xie Breakdown of academic impact, for papers by Susana P. Campos Breakdown of academic impact, for papers by C.E. Flück Breakdown of academic impact, for papers by Dor Mohammad Kordi-Tamandani Breakdown of academic impact, for papers by Ting Xie Breakdown of academic impact, for papers by Mireia Vilardell Breakdown of academic impact, for papers by Joshua Backman
Rankless by CCL
2026